Genmab, a global biotechnology company, has adopted ChatGPT Enterprise to enhance its operations and innovation capabilities. This decision leverages OpenAI’s strong commitment to security and privacy, ensuring that Genmab’s sensitive data and intellectual property are well protected.

By incorporating ChatGPT Enterprise, Genmab benefits from:

- **Advanced AI tools** to support research, development, and business processes.
- **Enhanced collaboration** among teams with AI-driven insights and automation.
- **Robust security features** including data encryption, compliance with privacy standards, and dedicated support from OpenAI.
- **Customizable AI solutions** tailored to the specific needs of the biotech industry.

This partnership highlights how cutting-edge AI technology, when combined with stringent security measures, can drive innovation in highly regulated sectors like biotechnology.